GSA Capital Partners »

Theravance Biopharma shares owned by GSA Capital Partners

Quarter-by-quarter ownership of Theravance Biopharma (TBPH) shares owned by GSA Capital Partners from 13F filings

Historical chart of GSA Capital Partners investment in Theravance Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Theravance Biopharma held by GSA Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Theravance Biopharma by GSA Capital Partners

Quarter filed Position value Share count Share price at filing
2023-12-31 $866k 77k 11.24
2023-09-30 $2.8M 326k 8.63
2023-06-30 $206k 20k 10.34
2023-03-31 $1.1M 105k 10.85
2022-12-31 $646k 58k 11.22
2022-06-30 $1.0M 115k 9.06
2022-03-31 $473k 50k 9.56
2020-09-30 $206k 14k 14.75
2019-09-30 $209k 11k 19.45